Silvercrest Asset Management’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.62M | Buy |
540,297
+82,269
| +18% | +$1.46M | 0.06% | 322 |
|
|
2025
Q1 | $8.16M | Buy |
458,028
+109,721
| +32% | +$1.96M | 0.06% | 330 |
|
|
2024
Q4 | $10.4M | Sell |
348,307
-147,804
| -30% | -$4.4M | 0.07% | 292 |
|
|
2024
Q3 | $7.75M | Buy |
496,111
+110,701
| +29% | +$1.73M | 0.05% | 307 |
|
|
2024
Q2 | $6.6M | Buy |
+385,410
| New | +$6.6M | 0.05% | 352 |
|
|
2021
Q1 | – | Sell |
-1,384
| Closed | -$239K | – | 865 |
|
|
2020
Q4 | $239K | Sell |
1,384
-1,787
| -56% | -$309K | ﹤0.01% | 751 |
|
|
2020
Q3 | $353K | Buy |
+3,171
| New | +$353K | ﹤0.01% | 648 |
|